BOOTHBAY FUND MANAGEMENT, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.6%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$2,312,711
-49.5%
50,952
-37.6%
0.06%
-45.0%
Q2 2023$4,581,024
+78.6%
81,600
+256.0%
0.10%
+40.8%
Q3 2021$2,565,000
-56.3%
22,919
-36.7%
0.07%
-62.4%
Q2 2021$5,866,000
+2615.7%
36,234
+1947.1%
0.19%
+2262.5%
Q1 2021$216,000
-80.0%
1,770
-92.3%
0.01%
-91.8%
Q2 2019$1,079,00022,9050.10%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 508,558$82,330,00027.28%
Valiant Capital Management, L.P. 307,700$49,814,0003.74%
NEA Management Company, LLC 1,590,002$257,405,0003.35%
NIA IMPACT ADVISORS, LLC 39,891$6,458,0003.15%
Ikarian Capital, LLC 200,000$32,379,0002.62%
Soleus Capital Management, L.P. 103,114$16,693,0002.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 157,334$25,471,0002.47%
Capital Impact Advisors, LLC 45,440$7,356,0002.37%
ARK Investment Management 7,776,119$1,258,876,0002.34%
Sassicaia Capital Advisers LLC 13,513$2,188,0002.28%
View complete list of CRISPR THERAPEUTICS AG shareholders